Geneva University Hospital is taking part in a global trial for a new treatment for ovarian cancer.
The cancer is particularly dangerous as it can’t be detected until it’s fairly far advanced.
The new technique delivers chemotherapy drugs through an aerosol, which means the drugs can be directly applied to the infected area.
That increases its effectiveness and reduces side effects.
It also allows the dosage to be significantly increased.
Ovarian cancer affects around 600 women a year in Switzerland – about two thirds will succumb to the disease.